Moolec Science SA Dossier
Qualitative Analysis
Business overview
Moolec Science SA is a pioneering science-based food ingredient company specializing in Molecular Farming, an innovative technology that produces real animal proteins inside plants. By engineering crops such as soybeans, peas, and safflower with animal gene codes, Moolec aims to upgrade the taste, texture, and nutritional profile of alternative proteins while maintaining a highly sustainable and cost-effective production model. Key proprietary platforms include Piggy Sooy™ (porcine protein expression in soybeans) and GLASO™ (high gamma-linolenic acid safflower oil). The company recently completed its redomiciliation from Luxembourg to the Cayman Islands in May 2025.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Scaling up the production of high-GLA (Gamma-Linolenic Acid) specialty oils using existing agricultural infrastructure in the United States, transitioning from development to full commercial deployment.
Expected impact: Establishes Moolec's presence in the pet food, human nutrition, and dietary supplement markets with high-purity functional lipids.
Developing high-performance and scalable feedstocks for the renewable energy transition by accessing a germplasm library of 386 safflower varieties from Australia.
Expected impact: Diversifies Moolec's molecular farming platform into the high-growth renewable energy sector, reducing reliance on food-only markets.
Advancing R&D and regulatory pathways for plants engineered to express animal proteins, including pork-protein soybeans (Piggy Sooy™) and bovine myoglobin in pea seeds.
Expected impact: Disrupts the alternative protein industry by providing animal-like functional ingredients at a plant-based cost structure.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Acquired 100% of Nutrecon to integrate its Mycofood™ product line under the Eternal® brand, expanding Moolec's alternative protein portfolio and adding state-of-the-art synthetic biology and precision fermentation platforms (Synbio Powerlabs).
Financial impact: Nutrecon shareholders received approximately 0.65 million shares of Moolec and 0.5 million private warrants.
Strategic Partnerships
Consolidates upstream regenerative agriculture technologies, biological inputs, and climate-smart seeds (Rizobacter®, ProFarm®, HB4®) with Moolec's molecular farming platform.
Terms: Bioceres Group shareholders exchanged their equity ownership for approximately 6.9 million shares of Moolec.
Provides Moolec with access to Insud's industrial capabilities and operational services to scale up precision fermentation and molecular farming product development.
Terms: Issued a $21 million convertible note due 2026 against $10 million cash and in-kind industrial contributions.